To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

More or Less is produced in partnership with the Open University. Presenter: Tim Harford Reporter: Lizzy McNeill Producer: ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

Maternal obesity doesn't just affect the health of a pregnant woman. It can also have effects on her child, increasing their ...

For years, people living with obesity have been given the same basic advice: eat less, move more. But while this mantra may ...

"Rhythm’s stock climbs on encouraging Phase II obesity drug data" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...